kynurenine has been researched along with Blood Pressure, Low in 4 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Kynurenine is a potential contributor to hypotension in animal and human sepsis." | 7.81 | Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels. ( Akahori, T; Feng, GG; Fujiwara, Y; Hatakeyama, N; Kinoshita, H; Li, J; Nakamura, E; Sakakibara, K; Yasuda, Y, 2015) |
"Patients (n = 16) with septic shock had indoleamine 2,3-dioxygenase activity assessed as the kynurenine-to-tryptophan ratio, and the severity of hypotension was determined by their inotrope requirements." | 7.77 | Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. ( Celermajer, DS; Changsirivathanathamrong, D; dos Remedios, CG; Duflou, J; Gebski, V; Maghzal, GJ; Mak, WM; Rajbhandari, D; Stocker, R; Wang, Y; Woolfe, C, 2011) |
"Kynurenine is a potential contributor to hypotension in animal and human sepsis." | 3.81 | Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels. ( Akahori, T; Feng, GG; Fujiwara, Y; Hatakeyama, N; Kinoshita, H; Li, J; Nakamura, E; Sakakibara, K; Yasuda, Y, 2015) |
"Patients (n = 16) with septic shock had indoleamine 2,3-dioxygenase activity assessed as the kynurenine-to-tryptophan ratio, and the severity of hypotension was determined by their inotrope requirements." | 3.77 | Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. ( Celermajer, DS; Changsirivathanathamrong, D; dos Remedios, CG; Duflou, J; Gebski, V; Maghzal, GJ; Mak, WM; Rajbhandari, D; Stocker, R; Wang, Y; Woolfe, C, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sakakibara, K | 1 |
Feng, GG | 1 |
Li, J | 1 |
Akahori, T | 1 |
Yasuda, Y | 1 |
Nakamura, E | 1 |
Hatakeyama, N | 1 |
Fujiwara, Y | 1 |
Kinoshita, H | 1 |
Changsirivathanathamrong, D | 1 |
Wang, Y | 1 |
Rajbhandari, D | 1 |
Maghzal, GJ | 1 |
Mak, WM | 1 |
Woolfe, C | 1 |
Duflou, J | 1 |
Gebski, V | 1 |
dos Remedios, CG | 1 |
Celermajer, DS | 1 |
Stocker, R | 1 |
Eiserich, JP | 1 |
Hayakawa, KA | 1 |
Cross, CE | 1 |
Oxenkrug, GF | 1 |
4 other studies available for kynurenine and Blood Pressure, Low
Article | Year |
---|---|
Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels.
Topics: Animals; Arteries; Dose-Response Relationship, Drug; Humans; Hypotension; In Vitro Techniques; Indol | 2015 |
Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hypotension; Indoleamine-Pyrrole 2,3,-Dioxygenase; I | 2011 |
Sepsis and hypotension: enter kynurenine, move over nitric oxide.
Topics: Female; Humans; Hypotension; Kynurenine; Male; Shock, Septic; Tryptophan | 2011 |
Kynurenine and hypotension: historic perspectives.
Topics: Female; Humans; Hypotension; Kynurenine; Male; Shock, Septic; Tryptophan | 2012 |